Preliminary Results from Retrospective Correlation of Circulating Tumor DNA (ct-DNA) with Imaging for HPV-Positive Oropharyngeal Squamous Cell Carcinoma

References

1. 1.↵
   1. Lechner M,
   2. Liu J,
   3. Masterson L, et al

   . HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol 2022;19:306–27 doi:10.1038/s41571-022-00603-7 pmid:35105976

   CrossRefPubMed
2. 2.↵
   1. Fakhry C,
   2. Westra WH,
   3. Li S, et al

   . Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–69 doi:10.1093/jnci/djn011 pmid:18270337

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Berger B,
   2. Hanna G,
   3. Posner M, et al

   . Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma. Clin Cancer Res 2022;28:4292–301 doi:10.1158/1078-0432.CCR-22-0562 pmid:35576437

   CrossRefPubMed
4. 4.↵
   National Comprehensive Cancer Network: Head and Neck Cancers (Version 3. 2024). https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed January 10, 2024
5. 5.↵
   1. Haring CT,
   2. Dermody SM,
   3. Yalamanchi P, et al

   . The future of circulating tumor DNA as a biomarker in HPV-related oropharyngeal squamous cell carcinoma. Oral Oncol 2022;126:105776 doi:10.1016/j.oraloncology.2022.105776 pmid:35183912

   CrossRefPubMed
6. 6.↵
   1. Dermody SM,
   2. Haring CT,
   3. Bhambhani C, et al

   . Surveillance and monitoring techniques for HPV-related head and neck squamous cell carcinoma: circulating tumor DNA. Curr Treat Options Oncol 2021;22:21 doi:10.1007/s11864-021-00821-8 pmid:33559043

   CrossRefPubMed
7. 7.↵
   1. Aulakh S,
   2. Silverman D,
   3. Young K, et al

   . The promise of circulating tumor DNA in head and neck cancer. Cancers (Basel) 2022;14:2968 doi:10.3390/cancers14122968

   CrossRef
8. 8.↵
   1. Chera B,
   2. Kumar S,
   3. Shen C, et al

   . Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer. J Clin Oncol 2020;38:1050–58 doi:10.1200/JCO.19.02444 pmid:32017652

   CrossRefPubMed
9. 9.↵
   1. Chera B,
   2. Kumar S,
   3. Beaty BT, et al

   . Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer. Clin Cancer Res 2019;25:4682–90 doi:10.1158/1078-0432.CCR-19-0211 pmid:31088830

   Abstract/FREE Full Text
10. 10.↵
    1. MacManus M,
    2. Kirby L,
    3. Blyth B, et al

    . Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC. Clin Transl Radiat Oncol 2023;43:100682 doi:10.1016/j.ctro.2023.100682 pmid:37808452

    CrossRefPubMed
11. 11.↵
    1. Hanna GJ,
    2. Patel N,
    3. Tedla SG, et al

    . Personalizing surveillance in head and neck cancer. Am Soc Clin Oncol Educ Book 2023;43:e389718 doi:10.1200/EDBK_389718 pmid:37079869

    CrossRefPubMed
12. 12.↵
    1. Abgral R,
    2. Querellou S,
    3. Potard G, et al

    . Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 2009;50:24–29 doi:10.2967/jnumed.108.055806 pmid:19091901

    Abstract/FREE Full Text
13. 13.↵
    1. O’Boyle C,
    2. Siravegna G,
    3. Varmeh S, et al

    . Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer. Cancer 2022;128:2193–204 doi:10.1002/cncr.34109 pmid:35139236

    CrossRefPubMed
14. 14.↵
    1. Mehanna H,
    2. Taberna M,
    3. von Buchwald C, et al

    ; HNCIG-EPIC Group. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncol 2023;24:239–51 doi:10.1016/S1470-2045(23)00013-X pmid:36796393

    CrossRefPubMed
15. 15.↵
    1. Prigge ES,
    2. Arbyn M,
    3. von Knebel M, et al

    . Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer 2017;140:1186–98 doi:10.1002/ijc.30516 pmid:27859245

    CrossRefPubMed